Combined d-penicillamine and chloroquine treatment of rheumatoid arthritis-a comparative study

Rheumatology

Volumn 26, Issue 4, 1987, Pages 279-284

  Gibson, T ^a   Emery, P ^a   Armstrong, R D ^a   Crisp, A J ^a   Panayi, G S ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Combination treatment; CRP; ESR; Radiographs; Rheumatoid factor

Indexed keywords

CHLOROQUINE; PENICILLAMINE;

DRUG THERAPY; HUMAN; JOINT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THERAPY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CHLOROQUINE; CLINICAL TRIALS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PENICILLAMINE; RHEUMATOID FACTOR;

EID: 0023184603     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/26.4.279     Document Type: Article

References (20)

1. Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DJ, Fries JF. Survival prognosis and causes of death in rheumatoid arthritis. Arthritis Rheum 1986;29:706-14.
2. Bitter T. Combined disease modifying chemo therapy for intractable rheumatoid arthritis. Clin Rheum Dis 1984;10:417-28.
3. Bunch TW, O’Duffy J, Tompkins R, O’Fallon W. Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis. Arthritis Rheum 1984;27:267-76.
4. Martin M, Dixon J, Hickling P, Bird H, Gold ing J, Wright V. A combination of d- penicillamine and hydroxychloroquine for the treatment of rheumatoid arthritis. Ann Rheum Dis 1982;41:208.
5. Butler D, Tiliakes N. Low dose cytotoxic drugcombination therapy in intractable rheumatoid arthritis. Arthritis Rheum 1985; 28(suppl):515.
6. Csuka ME, Carrera GF, McCarty D. Treat ment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine and hydroxychloroquine. JAMA 1986;255: 2315-9.
7. Ritchie DM, Boyle JA, Maclnnes JM, et al Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968; 147:393-406.
8. Richter MB, Woo P, Panayi GS, Trull A, Unger A, Shepherd P. The effects of intravenous methyl prednisolone on immunological and inflammatory process in ankylosing spondylitis. Clin Exp Immunol 1983;53: 51-9.
9. Faith A, Pontesilli D, Unger A, Panayi GS, Johns P. Elisa assays for IgM and IgG rheumatoid factor. J Immunol Methods 1982;55: 165-9.
10. Larsen A, Dale K, Eck M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol 1977;18:481-91.
11. Bombardier C, Tugwell P. Controversies in the analysis of longterm clinical trials of slow acting drugs. J Rheumatol 1985;12:403-5.
12. Hamilton EB, Scott JT. Hydroxychloroquine sulfate (Plaquenil) in treatment of rheu-matoid arthritis. Arthritis Rheum 1962;5: 502-11.
13. Scull E. Chloroquine and hydroxychloroquine therapy in rheumatoid arthritis. Arthritis Rheum 1962;5:30-6.
14. Runge LA. Risk benefit analysis of hydroxy chloroquine sulfate treatment in rheumatoid arthritis. Am J Med 1983;75:52-6.
15. Adams EM, Yocum DE, Bell CL. Hydroxy chloroquine in the treatment of rheumatoid arthritis. Am J Med 1983;75:321-6.
16. Popert AJ. Chloroquine: a review. Rheumatol Rehabil 1976;15:235-8.
17. Conference Proceedings. The place of anti- malarials in rheumatology. Ann Rheum Dis 1981;40:323-4.
18. Dawes PT, Fowler PD, Clarke S, Fisher J, Lawton A, Shadforth MF. Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression. Br J Rheumatol 1986;25:44-9.
19. Richter JA, Runge LA, Pinals RS, Oates RP. Analysis of treatment terminations with gold and antimalarial compounds in rheumatoid arthritis. J Rheumatol 1980;7:153-9.
20. Camp VA. Penicillamine in the treatment of rheumatoid arthritis. J Rheumatol 1981; 8(suppl 7): 103-6.